S. Kumar, J. L. Kaufman, and C. Gasparetto, Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma, Blood, vol.130, issue.22, pp.2401-2409, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01631468

E. A. Punnoose, J. D. Leverson, and F. Peale, Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models, Mol Cancer Ther, vol.15, issue.5, pp.1132-1144, 2016.

C. Touzeau, J. Ryan, and J. Guerriero, BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics, Leukemia, vol.30, issue.3, pp.761-764, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01411102

S. Maiga, C. Brosseau, and G. Descamps, A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines, Cytometry A, vol.87, issue.4, pp.285-288, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02100586

S. Surget, D. Chiron, and P. Gomez-bougie, Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex, Cancer Res, vol.72, issue.17, pp.8076-8079, 2005.

R. Hjerpe, F. Aillet, F. Lopitz-otsoa, V. Lang, P. England et al., Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities, EMBO Rep, vol.10, issue.11, pp.1250-1258, 2009.

C. Dousset, S. Maiga, and P. Gomez-bougie, BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma, Br J Haematol, vol.179, issue.4, pp.684-688, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01353369

M. Charrad, N. Ghazzali, V. Boiteau, and A. Niknafs, NbClust : An R Package for Determining the Relevant Number of Clusters in a Data Set, Journal of Statistical Software, issue.6, p.61, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01126479

V. Audigier, F. Husson, and J. Josse, Multiple imputation for continuous variables using a Bayesian principal component analysis, Journal of Statistical Computation and Simulation, vol.86, issue.11, pp.2140-2156, 2016.
URL : https://hal.archives-ouvertes.fr/hal-00951915

G. W. Foight, J. A. Ryan, S. V. Gulla, A. Letai, and A. E. Keating, Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells, ACS Chem Biol, vol.9, issue.9, pp.1962-1968, 2014.

M. Certo, D. Gaizo-moore, V. Nishino, and M. , Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members, Cancer Cell, vol.9, issue.5, pp.351-365, 2006.

T. Song, Z. Wang, and J. F. , Deactivation of Mcl-1 by Dual-Function Small-Molecule Inhibitors Targeting the Bcl-2 Homology 3 Domain and Facilitating Mcl-1 Ubiquitination, Angew Chem Int Ed Engl, vol.55, issue.46, pp.14250-14256, 2016.

J. N. Gong, T. Khong, and D. Segal, Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome, Blood, vol.128, issue.14, pp.3489-3495, 2007.

S. M. Schoenwaelder and S. P. Jackson, Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT263) and the modulation of cytosolic calcium flux and platelet function, Blood, vol.119, issue.5, pp.1321-1322, 2012.

D. Merino, J. R. Whittle, and F. Vaillant, Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer, Sci Transl Med, vol.9, issue.401, 2017.

P. Gomez-bougie, M. Halliez, P. Moreau, C. Pellat-deceunynck, and M. Amiot, Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis, Cancer Lett, vol.383, issue.2, pp.204-211, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01385221

A. Martine,

S. L. Rodriguez, C. Gouill, and . Touzeau,

P. Gomez-bougie, S. Maiga, B. Tessoulin, J. Bourcier, A. Bonnet et al., BH3-mimetics in myeloma treatment BH3-mimetic toolkit guides the respective use of, vol.2, p.1
URL : https://hal.archives-ouvertes.fr/inserm-01900681

, Information about subscriptions and ASH membership may be found online at: digital object identifier (DOIs) and date of initial publication. indexed by PubMed from initial publication. Citations to Advance online articles must include final publication), Information about reproducing this article in parts or in its entirety may be found online at